PNEUMONIA PRACTICE GUIDELINES

Similar documents
11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

Antibiotic Stewardship in LTC What does this mean?

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS

Geriatric Mental Health Partnership

ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies

Hot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital

Optimizing Antibiotic Stewardship in the ED

Understand the application of Antibiotic Stewardship regulations in LTC. Understand past barriers to antibiotic management concepts

Antibiotic Stewardship in the Neonatal Intensive Care Unit. Objectives. Background 4/20/2017. Natasha Nakra, MD April 28, 2017

Monthly Webinar. Tuesday 16th January 2018, 16:00. That Was The Year That Was : Selections from the 2017 Antimicrobial Stewardship Literature

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Reducing Time to Initial Antibiotic Dose in Pneumonia Patients

Suitability of Antibiotic Treatment for CAP (CAPTIME) The duration of antibiotic treatment in community acquired pneumonia (CAP)

Outpatient Antimicrobial Stewardship. Jeffrey S Gerber, MD, PhD Division of Infectious Diseases The Children s Hospital of Philadelphia

Antimicrobial Use Toolkit Webinar M A R C H 1 3,

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

Antimicrobial Stewardship

Define evidence based practices for selection and duration of antibiotics to treat suspected or confirmed neonatal sepsis

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

Antibiotic stewardship in long term care

Antimicrobial Stewardship:

ESISTONO LE HCAP? Francesco Blasi. Sezione Medicina Respiratoria Dipartimento Toraco Polmonare e Cardiocircolatorio Università degli Studi di Milano

Objectives 4/26/2017. Co-Investigators Sadie Giuliani, PharmD, BCPS Claude Tonnerre, MD Jayme Hartzell, PharmD, MS, BCPS

MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative

Antimicrobial Stewardship-way forward. Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi

Linda Taggart MD FRCPC Infectious Diseases Physician Lead Physician, Antimicrobial Stewardship Program St. Michael s Hospital

Antimicrobial Stewardship in the Outpatient Setting. ELAINE LADD, PHARMD, ABAAHP, FAARFM OCTOBER 28th, 2016

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD

Jump Starting Antimicrobial Stewardship

Measure Information Form

What is an Antibiotic Stewardship Program?

MAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges

Collecting and Interpreting Stewardship Data: Breakout Session

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC

IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP)

Core Elements of Antibiotic Stewardship for Nursing Homes

Using Data to Track Antibiotic Use and Outcomes

Role of the general physician in the management of sepsis and antibiotic stewardship

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

Update on CDC Antibiotic Stewardship Activities

Antibiotic Stewardship and Critical Access Hospitals. Robert White, BA, PT, CPHQ Program Manager TMF Quality Innovation Network

JOINT CONFERENCE COMMITTEE CORE MEASURE UPDATE APRIL 13, 2010

The Three R s Rethink..Reduce..Rocephin

Physician Rating: ( 23 Votes ) Rate This Article:

Healthcare-associated Infections and Antimicrobial Use Prevalence Survey

Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.

Antimicrobial Stewardship in the Hospital Setting

CLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:

ANTIBIOTIC STEWARDSHIP

1. List three activities pharmacists can implement to support. 2. Identify potential barriers to implementing antimicrobial

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK

INFECTIOUS DISEASES STRATEGIES TO LIMIT HOSPITALIZATION,REDUCE RISK AND ADD VALUE

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

4/4/2018. Pathway Health 1. Antibiotics - Are they OVERUSED?? Best Practice Approach to Antibiotic Stewardship: Essential Strategies for Compliance

Objective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest

IDSA GUIDELINES COMMUNITY ACQUIRED PNEUMONIA

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

Antimicrobial Stewardship Strategy: Intravenous to oral conversion

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities

Dr. Charles Onunkwo, Infectious Disease Medicine Erika Ingram, Infectious Disease/Critical Care Clinical Pharmacy Specialist Southeastern Regional

What Can ICPs do for stewardship

Protecting Patients and Antimicrobials Best Practices in Stewardship

Newsflash: Hospital Medicine JOHN C. CHRISTENSEN, MD FACP AMERICAN COLLEGE OF PHYSICIANS, UTAH CHAPTER SCIENTIFIC MEETING FEBRUARY 10, 2017

Antibiotic Stewardship in Human Health- Progress and Opportunities

Preventing and Responding to Antibiotic Resistant Infections in New Hampshire

Antimicrobial stewardship

Evaluating the Role of MRSA Nasal Swabs

Compliance with antibiotic treatment guidelines in managed care patients with communityacquired pneumonia in ambulatory settings

Disclosures. Astellas. The Medicines Company. Theravance Biopharma

Why Antimicrobial Stewardship?

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

Antibiotic Stewardship in the Hospital Setting

NUOVE IPOTESI e MODELLI di STEWARDSHIP

Antimicrobial Stewardship

Stewardship: Challenges & Opportunities in the Gulf Region

Safety of an Out-Patient Intravenous Antibiotics Programme

Antibiotic Stewardship in the LTC Setting

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

National Action Plan development support tools

Antimicrobial Stewardship. October 2012

The Law of Unintended Consequences

9/9/2015. Disclosure / Contact. Pneumonia Stats. Exploring the Clinical and Regulatory Impact of Pneumonia in Long Term Care

Treatment Duration for Uncomplicated Community-Acquired Pneumonia: The Evidence in Support of 5 Days

The Rise of Antibiotic Resistance: Is It Too Late?

Pneumonia considerations Galia Rahav Infectious diseases unit Sheba medical center

Antimicrobial Stewardship

Healthcare Facilities and Healthcare Professionals. Public

10/9/2017. Evidence-Based Interventions to Reduce Inappropriate Prescription of Antibiotics. Prescribing for Respiratory Tract Infections

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS

Advancing Antimicrobial Stewardship in Community and Rural Hospitals

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Supplementary Online Content

Best Practices: Goals of Antimicrobial Stewardship

Call-In Number: (888) Access Code:

Addressing ABX Resistance

BELIEFS AND PRACTICES OF PARENTS ON THE USE OF ANTIBIOTICS FOR THEIR CHILDREN WITH UPPER RESPIRATORY TRACT INFECTION

Transcription:

PNEUMONIA PRACTICE GUIDELINES WHERE ARE WE NOW STEPHEN SOKALSKI DO FACOI ADVOCATE CHRIST MEDICAL CENTER

PNEUMONIA GUIDELINES THEY SEEMED LIKE A GOOD IDEA AT THE TIME. ARE THEY STILL?

INDICATORS INCLUDED IN PNEUMONIA BUNDLE Oxygenation Assessment (Retired as of April 2009) Pneumoncoccal Screening and/or Vaccination Blood Culture 24-Hours Prior/after Arrival ICU Blood Cultures performed in the ED prior to initial antibiotic Adult Smoking Counseling Antibiotic Within 8-Hours 8 of Arrival (Retired as of October 2007) Antibiotic Within 6-Hours 6 of Arrival Antibiotic within 4-hours 4 of Arrival (Retired as of January 2009) Antibiotic Selection for ICU Patients Antibiotic Selection for Non-ICU Patients Influenza Vaccination Oct-March only

Impact on CMS Pneumonia Bundle 2006-2008 100% 97% 90% 86% Top Decile Goal = 93% 90% 94% 80% 70% 60% Top Decile Goal = 70 59% 61% 74% Top Decile Goal = 79% 73% 70% 75% System Goal = 70% 73% System Goal = 82% 50% System Goal = 57% 40% 30% 32% 20% 10% 0% 1st Qtr 06 2nd Qtr 06 3rd Qtr 06 4th Qtr 06 1st Qtr 07 2nd Qtr 07 3rd Qtr 07 4th Qtr 07 1st Qtr 08 2nd Qtr 08 3rd Qtr 08 4th Qtr 08

TAILORED INTERVENTIONS TO IMPROVE ANTIBIOTIC USE IN HOSPITALS JEROEN A SCHOUTEN

TAILORED INTERVENTIONS LOCAL BUY-IN, OPINION LEADERS INVOLVE ALL STAKEHOLDERS DISSEMINATE THE PLANS CONVENE LOCAL CONSENSIS CONFERENCES

TAILORED INTERVENTIONS ACADEMIC DETAILING PHARM D SUPPORT

TAILORED INTERVENTIONS COMPUTER AIDED DECISION SUPPORT CPOE

TAILORED INTERVENTIONS REMINDERS AUDITS FEEDBACK

CHALLENGES TO SUCCESS VERY TIME CONSUMING INITIALLY EXPENSIVE PHYSICIAN RESISTANCE NURSING RESISTANCE IS RESISTANCE ER RESISTANCE

CHALLENGES TO SUCCESS SEASONAL VARIATION TYPE OF PNEUMONIA, CAP,HCAP,HAP,VAP. LOCAL EPIDEMIOLOGY [NURSING HOMES, OTHER HOSPITALS]. PREVIOUS OUT PATIENT ANTIBIOTICS

ER CHALLENGES >85% OF PNEUMONIAS ADMITTED FROM ER LARGE ER STAFF TO STANDARDISE ARRIVAL TIME IN ER TRIAGE TIME TO PHYSICIAN EVALUATION TIME TO XRAY TIME TO XRAY REPORT TIME TO NOTIFICATION OR ER DOC

ER CHALLENGES TIME TO ADMINISTRATION OF ABX AVAILABILITY OF ABX IN ER, OMNICELL BLOOD CULTURES PRIOR TO ADMINISTRATION ABGS, LABS, CULTURES, FLU STUDIES,SPUTUM STUDIES TIMING OF BLOOD DRAWS AND LAB RESULTS

ER CHALLENGES PATIENT HISTORY SYMPTOMS PREVIOUS ANTIBIOTICS EXPOSURE TO OTHERS UNDERLYING DISEASE AND IMMUNE STATUS LESS THAN COMPLETE ECF RECORDS

ER CHALLENGES OVERCROWDING TRAUMA, MI, CHF, DKA, ASTHMA ETC. OUTBREAK SITUATIONS PEDS VS ADULTS FACILITY DESIGN

GUIDELINES PERFORMANCE HOW DID WE IMPROVE? LEADING INDICATORS ER CHANGES XRAY TIMING XRAY INTERPRETATION, REPORT AT ONCE, INDETERMINATE CLASSIFICATION ANTIBIOTICS ON HAND HIGH PRIORITY DIAGNOSIS AUTOMATIC LABS, CHECK LIST

GUIDELINES PERFORMANCE NURSING CONTRIBUTIONS HIGH PRIORITY TO ADMITS FROM OFFICE STATE OF THE UNIT REPORT PRIORITIZE PC AND FLU VACCINES ICU ADMITS VACCINES PHYSICIAN COMPLIANCE MAGNET NURSING INFLUENCE

MISDIAGNOSIS OF CAP AND INAPPROPRIATE UTILIZATION OF ANTIBIOTICS SIDE EFFECTS OF THE 4-H 4 H ANTIBIOTIC ADMINISTRATION RULE CHEST Manreet Kanwar et. al.

EFFECTS OF 4H DEADLINE AND LINKS TO COMPENSATION 608 BED TEACHING HOSPITAL PRE AND POST GUIDELINE REQUIREMENT MORE PATIENTS HAD AN ADM. DIAGNOSIS OF CAP WITHOUT RADIOLOGIC ABNORMALITIES 28.5% VS 20.6% p=0.04 MORE RECEIVED ABX.<4H AFTER TRIAGE 65.8% VS 53.8% p=0.007

EFFECTS OF 4H STANDARD BLOOD CULTURES PRIOR TO ANTIBIOTICS INCREASED 69.9% VS 46.7% p=0.001 FINAL DIAGNOSIS OF CAP DECREASED 58.9%VS75.9% p<0.001 MEAN ANTIBIOTIC UTILIZATION INCREASED FROM 1.39 TO 1.66

RESULTS OF 4H STANDARD WAS THERE ANY BENEFIT TO FOLLOWING THE STANDARD? WAS LINKING THE PERFORMANCE TO THE STANDARD AN ADVANTAGE FOR PATIENT CARE? THE 2007 IDSA GUIDELINES NOW SAY THAT THE ANTIBIOTIC SHOULD BE ADMINISTERED WHILE STILL IN THE ER. CMS HAS YET TO CHANGE THEIR STANDARD WHICH WAS LOWERED TO 6H

CAP GUIDELINES REVISITED PERFORMANCE MEASURES IN COMMUNITY-ACQUIRED PNEUMONIA:CONSEQUENCES INTENDED AND UNINTENDED CID Thomas M File, Jr., and Peter A Gross

TWO MEASURES FOUND TO BE POTENTIALLY ASSOCIATED WITH OVERUSE OF ANTIMICROBIALS 1.BLOOD CULTURES 2. TIME TO FIRST DOSE

BLOOD CULTURES FREQUENTLY FALSE POSITIVE IN THIS SETTING GRAM POSITIVE COCCI/CLUSTERS COAG. NEG. STAPH. OVER USE OF VANCOMYCIN EXTEND LOS ONE DAY LIMITED USE NOW DRAW WITHIN 24H FOR PATIENTS ADMITTED TO ICU

TIME TO FIRST DOSE OF ANTIBIOTIC INITIALLY FOUR HOURS CHANGED TO 6 HOURS NOW NECESSARY BEFORE TRANSFER FROM ER FOUR HOUR WINDOW HAS LED TO ADMINISTRATION OF ABX PRIOR TO CONFIRMATION OF PNEUMONIA

REMEDIES REALISTIC LIMIT, NOT 100% OTHER WISE GAMING THE SYSTEM IS SEEN DEVIATION IS ACCEPTABLE IF THE REASON IS WELL DOCUMENTED IN THE CHART TARGET AN EVIDENCE-BASED BENCHMARK THRESHOLD FOR EACH INDICATOR

CODEING CODEING CODEING ICD-9 9 CODES DEPEND ON THE ATTENDING PHYSICIAN S DOCUMENTATION OFTEN ARE NOT REVISED TO REFLECT THE TRUE DIAGNOSIS BY DISCHARGE OFTEN DON T REFLECT CONSULTANTS OPINIONS OR LAB AND RADIOLOGY DIAGNOSES CAN LEAD TO HIGH UNSUPPORTED MORTALITIES

GUIDELINE TYRANNY:PRIMUM NON NOCERE Stephen G Baum and Anna Kaltsas Clinical Infectious Disease 2008;46:1879-80 80

GUIDELINE TYRANNY 1997 Single Publication improved survival rates if ABX<8h after ER admission. 15% lower odds of mortality. CMS-sponsored slight improvement if <4h after ER admission. Critics said: Increased Mortality in CMS study if ABX<2h. ABX take several days to impact outcome!

GUIDELINE TYRANNY Common atypical presentations of CAP in aged [altered mental status] may be markers of a poor prognosis. These co-morbidities in aged and atypical presentations, rather than delay, may be the causes of adverse outcomes. Early treatment of CAP may actually reflect EGDTSAS and lead to better outcomes.

GUIDELINE TYRRANY These questionable guidelines now have been adopted as a standard of care and, in many states, one of the core measures for quality. Pay for performance has also been added to this far-reaching reaching policy based on little evidence.

GUIDELINE TYRRANY Pay for Performance based on suspect evidence causes harm by increasing the overuse of antibiotics. 29% of CAP cases actually have a viral infection 60% of hospitalized CAP cases never have an etiology proven. ½ of patients treated within 4h have pneumonia which is not susceptible to the ABX

GUIDELINE TYRRANY 50% of patients who fail CAP treatment actually have CHF, interstitial pulmonary fibrosis, Wegner granulomatosis,, PE, cryptogenic organizing pneumonia or other causes of the infiltrates. Overuse of ABX leads to c-diff, c MDROs, ESBLs,VRE,, fungi and other resistant organisms.

GUIDELING TYRRANY THE ACCREDITING AND FUNDING AGENCIES SHOULD NOT USE THE APPLICATION OF THESE TIMING GUIDELINES TO MEASURE QUALITY OF CARE OR PAY FOR PERFORMANCE.

IDSA GUIDELINE CONCERNS 100% compliance was never the goal!

IDSA ISSUES Guidelines were written based on general recommendations for the majority of patients Patient variation and local epidemiology may justify variation in treatment. Pay for Performance neglects the medical variation. Appropriate High and Low thresholds need to be established.

CMS PUBLICLY REPORTED MEASUREMENTS NEW LEVELS OF COMPLEXITY

CMS Readmission rates. CMS has asked hospitals to review CMS reports on readmissions for pneumonia, heart failure and heart attack for 7/1 2005 to 6/30/2008. There is no publicly available software to access accuracy of results on numerator cases.

CMS ICD-9 9 coding conventions are often not reflective of the true patient status The codes reflect the attending physician s progress notes and not the opinion of consultants or lab data. Each code is arrived at then placed into a software program for highest payment rather than relative clinical value

CMS Even if a patient may not follow the prescribed care or instructions post discharge the hospital will still be assigned a re-admission within 30 days of discharge.

CMS Hospitals are now required to influence the care of patients after discharge. This means coordination of care with ECFs, attending physicians and regular contact with families and healthcare providers.

CMS The issue of hospice designation is confused in the bureaucracy. We are accused of assigning patients to hospice because inappropriate therapy fails. We are penalized for readmission in <30 days when the patients are readmitted to hospice on the same day.

DANGER AHEAD POLITICS INTRUDE IN IDSA GUIDELINE FOR LYME DISEASE

AG OF CONNECTICUT v IDSA 2006 LYME DISEASE GUIDELINES CONSPIRACY WHICH IS IN RESTRAINT OF TRADE OR COMMERCE. GUIDELINES ARE COMMONLY APPLIED BY INSURANCE COMPANIES TO REFUSE EXCEPTIONAL TREATMENT

AG v IDSA GUIDELINES STRONGLY INFLUENCE PHYSICIAN TREATMENT DECISIONS CONCLUDE THAT CHRONIC LYME DISEASE IS NONEXISISTANT

EFFECTS OF AG v IDSA OVERSIGHT BY PEOPLE WHO ARE NOT EXPERTS IN LYME DISEASE OMBUDSMAN NEW ID PHYSICIANS WHO HAVE NOT PUBLISHED ON LYME DISEASE AND DID NOT CONTRIBUTE TO THE 2006 GUIDELINES TO REVIEW AND REVISE GUIDELINES IF NECESSARY

EXPERTS WHO PROVIDE THEIR EXPERTISE ARE NOW DISCOURAGED TO DO SO FOR FEAR OF LITIGATION OR PUBLIC HARRASMENT BY SPECIAL INTEREST GROUPS WHAT HAVE WE COME TO? IS SCIENCE DEAD IN THE US EXCEPT FOR A FEW BELIEVERS?

References Public Reporting of Antibiotic Timing in Patients with Pneumonia: : Lessons from a Flawed Performance Measure Robert M. Wacter,, MD; Scott A. Flanders, M.D./; Christopher Fee, M.D.; and Peter r J. Pronovost,, MD, PhD Ann Intern Med. 2008; 149-29 29-32. Tailored Interventions to Improve Antibiotic Use for Lower Respiratory Tract Infections in Hospitals: A Cluster-Randomized, Controlled Trial Clinical Infectious Diseases 2007;44:931-41 41 Danger Ahead: Politics Intrude in Infectious Diseases Society of America Guideline for Lyme Disease Clinical Infectious Diseases 2008; 47:1197-9 Misdiagnosis of Community-Acquired Pneumonia and Inappropriate Utilization of Antibiotics CHEST 2007; 131:1865-1869 1869 Performance Measurement in Community-Acquired Pneumonia: Consequences Intended and Unintended Clinical Infectious Diseases 2007;44:942-4 Guideline Tyranny: Primum non nocere Clinical Infectious Diseases 2008; 46:1879-80 80 Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults Clinical Infectious Diseases 2003; 37:1405-33 33